AAAAAA
Results:
1-10
|
Results: 10
Authors:
CURE H
KRAKOWSKI I
ADENIS A
TUBIANA N
KERBRAT P
ROCHE H
CHEVALLIER B
LENTZ MA
FUMOLEAU P
CHOLLET P
Citation: H. Cure et al., RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/, European journal of cancer, 34(3), 1998, pp. 422-423
Authors:
MURACCIOLE X
BONNIER P
DELABY F
BERARD H
TUBIANA N
BENYOUB S
HADJADJ D
PIANA L
JUIN P
Citation: X. Muracciole et al., CONCOMITANT RADIOCHEMOTHERAPY WITH OR WITHOUT SURGERY IN POOR PRONOSTIC CERVICAL-CANCER - A PILOT-STUDY, European journal of cancer, 33, 1997, pp. 959-959
Authors:
LEBEAU B
DEPIERRE A
GIOVANNINI M
RIVIERE A
KALUZINSKI L
VOTAN B
HEDOUIN M
DALLENS H
AUBIER M
BACHAUD JM
BALMES P
BERNARD JP
BIRON E
BONNAUD F
BONSROSSET F
BOUFFETTE P
BOYER J
BRUNET R
CAILLAUD D
CALAIS G
CAPDEVILLE J
CATRYTHOMAS I
CHAUMIER P
CHAVAILLON JM
CHEVALLIER B
CLAVIER J
CONSTANS P
CUPISSOL D
DAVID P
DELZENNE A
DERENNE JP
ESCAMILLA R
EYMARD JC
FABBRO M
FABRE V
FAYOLLE V
FOURNEL P
FRANCHI C
FRUGE I
GUERIN JC
GOUEROU H
HADJADJ D
KELKEL E
LACROIX H
LEBOURGEOIS JP
LEBRUN D
LUCAS P
MARTIN M
MARTY M
MATHIEU JP
MEURISSE MP
MITAL P
MORO D
MUIR JF
ORFEUVRE H
PERPOINT B
QUOIX E
REBISCHUNG JL
REBOULET V
RIOU R
SALTIEL JC
SLAWINSKI JC
SEVIN D
TAULELLE M
TUBIANA N
VOLOCH A
WEITZENBLUM E
ZYLBERBERG R
Citation: B. Lebeau et al., THE EFFICACY OF A COMBINATION OF ONDANSETRON, METHYLPREDNISOLONE AND METOPIMAZINE IN PATIENTS PREVIOUSLY UNCONTROLLED WITH A DUAL ANTIEMETIC TREATMENT IN CISPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 8(9), 1997, pp. 887-892
Authors:
COMTE L
LORGEOT V
VOLKOV L
ROULLET B
TUBIANA N
PRALORAN V
Citation: L. Comte et al., ACSDKP PLASMA-CONCENTRATIONS IN PATIENTS WITH SOLID TUMORS - COMPARISON OF 2 CHEMOTHERAPEUTIC REGIMENS, Cancer letters, 112(1), 1997, pp. 1-4
Authors:
BONNETERRE J
TUBIANAHULIN M
CHOLLET P
CHEVALLIER B
FUMOLEAU P
KERBRAT P
VIE B
KHAYAT D
TUBIANA N
LEJEUNE C
LEGRAND A
SOARES JA
PELLAECOSSET B
Citation: J. Bonneterre et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 354-354
Authors:
LHOMME C
GUASTALLA JP
DAUPLAT J
FERRERO JM
OBERLING F
VENNIN P
POUILLART P
FUMOLEAU P
KERBRAT P
TUBIANA N
HERON JF
BUGAT R
BACHELOT T
SCHREINEROVA M
FLEURY J
NAMER M
DUFOUR P
DIERAS V
SOLARMICHEL P
PRUVOT I
CHANEZ MA
GARET F
CHAZARD M
PELLAECOSSET B
Citation: C. Lhomme et al., A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC), European journal of cancer, 31A, 1995, pp. 507-507
Authors:
DIERAS V
MARTY M
TUBIANA N
CORETTE L
MORVAN F
SERIN D
MIGNOT L
CHAZARD M
GARET F
ONETTO N
HELLMANN S
POUILLART P
Citation: V. Dieras et al., PHASE-II RANDOMIZED STUDY OF PACLITAXEL VERSUS MITOMYCIN IN ADVANCED BREAST-CANCER, Seminars in oncology, 22(4), 1995, pp. 33-39
Authors:
BONNIER P
CHARPIN C
LEJEUNE C
ROMAIN S
TUBIANA N
BEEDASSY B
MARTIN PM
SERMENT H
PIANA L
Citation: P. Bonnier et al., INFLAMMATORY CARCINOMAS OF THE BREAST - A CLINICAL, PATHOLOGICAL, OR A CLINICAL AND PATHOLOGICAL DEFINITION, International journal of cancer, 62(4), 1995, pp. 382-385
Authors:
BONNIER P
ROMAIN S
CHARPIN C
LEJEUNE C
TUBIANA N
MARTIN PM
PIANA L
Citation: P. Bonnier et al., AGE AS A PROGNOSTIC FACTOR IN BREAST-CANCER - RELATIONSHIP TO PATHOLOGICAL AND BIOLOGIC FEATURES, International journal of cancer, 62(2), 1995, pp. 138-144
Authors:
ROSSI JF
BOUABDALLAH R
FUZIBET JG
LEPEU G
MARTIN C
GRIS JC
MARIT G
KUGEL C
CAPDEVILA V
TUBIANA N
LEJEUNE C
BATAILLE R
SOTTO JJ
Citation: Jf. Rossi et al., RESULT OF RANDOMIZED STUDY COMPARING MELPHALAN-PREDNISONE (MP) TO ALTERNATING MP AND HYDROXYUREA-VAD (VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, HVAD) IN 148 PATIENTS WITH MULTIPLE-MYELOMA (MM), Blood, 86(10), 1995, pp. 735-735
Risultati:
1-10
|